CC

Commodore Capital Portfolio holdings

AUM $1.73B
1-Year Est. Return 298.96%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+298.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.5B
AUM Growth
-$546M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
43
New
Increased
Reduced
Closed

Top Buys

1
+$23M
2
+$22M
3
+$21.4M
4
ALKS icon
Alkermes
ALKS
+$13.6M
5
REPL icon
Replimune Group
REPL
+$12.1M

Top Sells

1
+$332M
2
+$142M
3
+$97.6M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$93.9M
5
NUVL icon
Nuvalent
NUVL
+$83.8M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLAY icon
1
Relay Therapeutics
RLAY
$3.33B
$144M 9.57%
17,000,000
ALKS icon
2
Alkermes
ALKS
$7.23B
$99.3M 6.61%
3,550,000
+453,246
TYRA icon
3
Tyra Biosciences
TYRA
$1.62B
$88.7M 5.91%
3,375,000
XENE icon
4
Xenon Pharmaceuticals
XENE
$5.12B
$80.7M 5.37%
1,800,000
-900,000
SYRE icon
5
Spyre Therapeutics
SYRE
$6.82B
$78.2M 5.21%
2,388,245
+400,161
COGT icon
6
Cogent Biosciences
COGT
$5.51B
$78M 5.19%
2,196,845
-5,053,155
ELVN icon
7
Enliven Therapeutics
ELVN
$2.19B
$72.3M 4.81%
4,692,809
CLDX icon
8
Celldex Therapeutics
CLDX
$2.34B
$69.7M 4.64%
2,565,000
-463,335
AMLX icon
9
Amylyx Pharmaceuticals
AMLX
$1.59B
$68.3M 4.54%
5,650,000
+1,574,522
TERN
10
DELISTED
Terns Pharmaceuticals
TERN
$59.6M 3.97%
1,475,000
-4,225,000
KYMR icon
11
Kymera Therapeutics
KYMR
$6.02B
$58.4M 3.88%
750,000
SLNO
12
DELISTED
Soleno Therapeutics
SLNO
$55.6M 3.7%
1,200,000
-150,000
NUVL icon
13
Nuvalent
NUVL
$7.43B
$55.3M 3.68%
550,000
-850,000
ORKA
14
Oruka Therapeutics
ORKA
$3.76B
$53.1M 3.54%
1,753,054
PHVS icon
15
Pharvaris
PHVS
$2.11B
$52.4M 3.49%
1,889,445
-529,031
NRIX icon
16
Nurix Therapeutics
NRIX
$1.6B
$43.2M 2.87%
2,275,000
-1,505,055
PTGX icon
17
Protagonist Therapeutics
PTGX
$6.61B
$39.3M 2.62%
450,000
-575,000
ASMB icon
18
Assembly Biosciences
ASMB
$487M
$34M 2.26%
1,000,000
LBRX
19
LB Pharmaceuticals
LBRX
$802M
$33.4M 2.22%
1,500,000
CTMX icon
20
CytomX Therapeutics
CTMX
$701M
$32.8M 2.18%
7,692,300
ANRO icon
21
Alto Neuroscience
ANRO
$662M
$32.5M 2.16%
+1,823,196
PALI icon
22
Palisade Bio
PALI
$335M
$26.9M 1.79%
+11,445,000
DFTX
23
Definium Therapeutics
DFTX
$2.57B
$26.8M 1.78%
2,000,000
-1,225,000
CNTA
24
Centessa Pharmaceuticals
CNTA
$6.17B
$25M 1.66%
1,000,000
-1,850,000
PEPG icon
25
PepGen
PEPG
$98.2M
$22.1M 1.47%
3,400,000
+1,042,681
1
2